Cargando…
Performance of leflunomide as a steroid-sparing agent in giant cell arteritis: A single-center, open-label study
BACKGROUND: The management of giant cell arteritis (GCA) remains challenging and many patients require prolonged glucocorticoid treatment due to high disease relapse rates. We aimed to evaluate the role of leflunomide as a steroid-sparing agent in GCA. METHODS: This prospective open-label study incl...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684628/ https://www.ncbi.nlm.nih.gov/pubmed/36438047 http://dx.doi.org/10.3389/fmed.2022.1069013 |